Image from Amazon.com
Biosimilarity : the FDA perspective / Sarfarz K. Niazi.
Publisher: Boca Raton : CRC Press, Taylor & Francis Group, [2019]Description: xxxvii, 397 pages : color illustrations ; 27 cmContent type:- text
- unmediated
- volume
- 9781498750394 (hardcover : acid-free paper)
| Item type | Current library | Home library | Collection | Call number | Materials specified | Copy number | Status | Date due | Barcode | |
|---|---|---|---|---|---|---|---|---|---|---|
| AM | PERPUSTAKAAN DR ABDUL LATIFF | PERPUSTAKAAN DR ABDUL LATIFF KOLEKSI AM-P. DR ABDUL LATIFF | - | QV241.N577b 2019 9 (Browse shelf(Opens below)) | 1 | Available | 00002237862 |
Browsing PERPUSTAKAAN DR ABDUL LATIFF shelves, Shelving location: KOLEKSI AM-P. DR ABDUL LATIFF Close shelf browser (Hides shelf browser)
|
|
|
|
|
|
|
||
| QV241.C517 2013 9 Chemistry and pharmacology of naturally occurring bioactive compounds / | QV241.N285 2014 9 Natural bioactive molecules : impacts and prospects / | QV241.N285 2015 9 Natural products chemistry : sources, separations and structures / | QV241.N577b 2019 9 Biosimilarity : the FDA perspective / | QV247.M612 2010 9 Meyler`s side effects of analgesics and anti-inflammatory drugs / | QV25 .C443a 1985 9 n.1 Analysis of drugs in biological fluids / | QV25 .P535 1981 9 Pharmaceutical analysis : modern methods / |
Includes bibliographical references and index.
There are no comments on this title.
Log in to your account to post a comment.